PATRIOT Trial: Randomized phase II study of prostate stereotactic body radiotherapy comparing 11 versus 29 days overall treatment time

被引：6
|
作者：
Quon, Harvey Charles
Ong, Aldrich
Cheung, Patrick
Chu, William
Chung, Hans T.
Vesprini, Danny
Chowdhury, Amit
Panjwani, Dilip
Pang, Geordi
Korol, Renee
Davidson, Melanie
Ravi, Ananth
McCurdy, Boyd
Zhang, Liying
Bucher, Oliver
Mamedov, Alexandre
Deabreu, Andrea
Lylyk, Elizabeth
Loblaw, Andrew
机构：
[1] CancerCare Manitoba, Winnipeg, MB, Canada
[2] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Toronto, ON M4N 3M5, Canada
[3] BC Canc Agcy, Abbotsford, BC, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 07期
关键词：
D O I：
10.1200/jco.2015.33.7_suppl.6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Preliminary toxicity analysis of a phase I/II trial evaluating stereotactic body radiotherapy for the treatment of hepatocellular carcinoma
    Henderson, M. A.
    Azzouz, F.
    Breen, T.
    DeLuca, J.
    Tudor, K.
    Cardenes, H. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S297 - S297
  • [42] Primary Outcomes of a Phase II Randomized Trial of Observation Versus Stereotactic Ablative RadiatIon for OLigometastatic Prostate CancEr (ORIOLE)
    Phillips, R.
    Lim, S. J.
    Shi, W. Y.
    Antonarakis, E. S.
    Rowe, S.
    Gorin, M.
    Deville, C., Jr.
    Greco, S. C.
    Denmeade, S.
    Paller, C.
    DeWeese, T. L.
    Song, D.
    Wang, H.
    Carducci, M.
    Pienta, K.
    Pomper, M. G.
    Dicker, A. P.
    Eisenberger, M.
    Diehn, M.
    Tran, P. T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (03): : 681 - 681
  • [43] Five-year outcomes of fractionated stereotactic body radiotherapy for oligometastatic prostate cancer from the TRANSFORM phase II trial
    See, Andrew W.
    Conway, Paul
    Frydenberg, Mark
    Haxhimolla, Hodo
    Costello, Anthony J.
    Moon, Daniel
    Ruljancich, Paul
    Grummet, Jeremy
    Pranavan, Ganes
    Peters, Justin
    Smyth, Lloyd M. L.
    Gwini, Stella M.
    Mckenzie, Dean P.
    Bowden, Patrick
    INTERNATIONAL JOURNAL OF CANCER, 2024, 155 (07) : 1248 - 1256
  • [44] Randomised phase II trial of stereotactic body radiotherapy in combination with checkpoint inhibitors in metastatic castration-resistant prostate cancer (CheckPRO): a study protocol
    Spindler, Nicklas Juel
    Persson, Gitte Fredberg
    Theile, Susann
    Nielsen, Dorte Lisbeth
    Hogdall, Estrid, V
    Al-Farra, Gina
    Hendel, Helle Westergren
    Lorentzen, Torben
    Svane, Inge Marie
    Lindberg, Henriette
    Eefsen, Rikke Lovendahl
    BMJ OPEN, 2023, 13 (01):
  • [45] A treatment planning study comparing IMRT techniques and cyber knife for stereotactic body radiotherapy of low-risk prostate carcinoma
    Sergiu Scobioala
    Christopher Kittel
    Khaled Elsayad
    Kai Kroeger
    Michael Oertel
    Laith Samhouri
    Uwe Haverkamp
    Hans Theodor Eich
    Radiation Oncology, 14
  • [46] A treatment planning study comparing IMRT techniques and cyber knife for stereotactic body radiotherapy of low-risk prostate carcinoma
    Scobioala, Sergiu
    Kittel, Christopher
    Elsayad, Khaled
    Kroeger, Kai
    Oertel, Michael
    Samhouri, Laith
    Haverkamp, Uwe
    Eich, Hans Theodor
    RADIATION ONCOLOGY, 2019, 14 (01)
  • [47] A treatment planning study comparing IMRT techniques and Cyber Knife for stereotactic body radiotherapy of low-risk prostate carcinoma
    Scobioala, S.
    Kittel, C.
    Elsayad, K.
    Kroeger, K.
    Oertel, M.
    Haverkamp, U.
    Eich, H. T.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 : S85 - S85
  • [48] Randomized phase II study comparing topotecan/cisplatin administration for 5 days versus 3 days in the treatment of extensive stage small cell lung cancer (SCLC)
    Seifart, U
    Jensen, K
    Ukena, J
    Mueller, C
    Schröder, M
    Fuhr, HG
    Keppler, U
    Neubauer, A
    Staab, HJ
    Wolf, M
    LUNG CANCER, 2005, 48 (03) : 415 - 422
  • [49] Prospective Randomized Phase II Study of Stereotactic Body Radiotherapy (SBRT) vs. Conventional Fractionated Radiotherapy (CFRT) for Chinese Patients with Early-Stage Localized Prostate Cancer
    Poon, Darren M. C.
    Lam, Daisy
    Wong, Kenneth C. W.
    Chu, Cheuk-Man
    Cheung, Michael
    Mo, Frankie
    Suen, Joyce
    Ng, Chi-Fai
    Chan, Anthony T. C.
    CURRENT ONCOLOGY, 2022, 29 (01) : 27 - 37
  • [50] PROSTATE SBRT BOOST RADIOTHERAPY (PBS TRIAL): A RANDOMIZED PHASE II TRIAL OF SBRT VERSUS CONVENTIONALLY-FRACTIONATED RADIOTHERAPY BOOST FOLLOWING PELVIC RADIOTHERAPY IN HIGH-RISK PROSTATE CANCER
    Mesci, Aruz
    Isfahanian, Naghmeh
    Douvi, Georgia
    Gouran-Savadkoohi, Mohammad
    Dayes, Ian
    Lukka, Himanshu
    Quan, Kimmen
    Schnarr, Kara
    Goldberg, Mira
    Hallock, Abhirami
    Chow, Tom
    Diamond, Kevin
    Jakubovic, Raphael
    Thabane, Lahane
    Tsakiridis, Theodoros
    RADIOTHERAPY AND ONCOLOGY, 2021, 163 : S64 - S64
12345